Department of Vitreoretinal Surgery, Barraquer Institute, Universitat Autònoma de Barcelona, Barcelona, Spain.
JAMA Ophthalmol. 2013 Aug;131(8):1083-5. doi: 10.1001/jamaophthalmol.2013.426.
The use of antibody to vascular endothelial growth factor to treat neovascular glaucoma yields good anatomic results in most cases. However, this type of glaucoma can cause angle closure with decompensation of intraocular pressure secondary to fibrovascular tissue contraction in the anterior chamber. Our surgical technique treats the cause by removing the anterior chamber fibrous complex after administration of antibody to vascular endothelial growth factor, thus restoring the chamber angle.
使用血管内皮生长因子抗体治疗新生血管性青光眼在大多数情况下可获得良好的解剖学结果。然而，这种类型的青光眼可引起房角关闭，并伴有眼内压失代偿，这是由于前房纤维血管组织收缩所致。我们的手术技术通过在使用血管内皮生长因子抗体后切除前房纤维复合物来治疗病因，从而恢复房角。
